Regenxbio RGNX
NASDAQ RGNX
$7.26 -0.14 (-1.82%)
As of: Oct 21, 2026 · 11:41 AM EDT

Regenxbio (RGNX) Minority Interest (2014)

Updated

Regenxbio's Minority Interest was $12.59 million in Q4 2014.

Analysis

Regenxbio (RGNX) Minority Interest (2014) Analysis & Trends

  • In earlier years, Minority Interest was $23.56 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Regenxbio 384.79 Mn -548.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 12.59 Mn
API Access

Regenxbio Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=RGNX&period=max&api_key=YOUR_API_KEY